Innovation Under Regulatory Uncertainty: Evidence from Medical Technology
作者： Ariel Dora Stern
DOI: 10.2139/SSRN.2853173
关键词:
摘要: … regulatory approval process affects innovation incentives in medical … And under what circumstances do we expect firms to … Previous studies of medical innovation under FDA regulation …
sci-hub.se 参考文章(27)
S. Raymond Golish, Michael L. Reed, Spinal devices in the United States-investigational device exemption trials and premarket approval of class III devices. The Spine Journal. ,vol. 17, pp. 150- 157 ,(2017) , 10.1016/J.SPINEE.2016.09.015
D. Acemoglu, J. Linn, Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry Quarterly Journal of Economics. ,vol. 119, pp. 1049- 1090 ,(2004) , 10.1162/0033553041502144
Daniel Carpenter, Michael M. Ting, Regulatory Errors with Endogenous Agendas American Journal of Political Science. ,vol. 51, pp. 835- 852 ,(2007) , 10.1111/J.1540-5907.2007.00284.X
Daniel P. Carpenter, Groups, the Media, Agency Waiting Costs, and FDA Drug Approval American Journal of Political Science. ,vol. 46, pp. 490- ,(2002) , 10.2307/3088394
DANIEL P. CARPENTER, Protection without Capture: Product Approval by a Politically Responsive, Learning Regulator American Political Science Review. ,vol. 98, pp. 613- 631 ,(2004) , 10.1017/S0003055404041383
D. Carpenter, S. I. Moffitt, C. D. Moore, R. T. Rynbrandt, M. M. Ting, I. Yohai, E. J. Zucker, Early Entrant Protection in Approval Regulation: Theory and Evidence from FDA Drug Review Journal of Law Economics & Organization. ,vol. 26, pp. 515- 545 ,(2010) , 10.1093/JLEO/EWP002
Alexander Billioux, , Katherine Verlander, Susan Anthony, Dawn Alley, , , , Standardized Screening for Health-Related Social Needs in Clinical Settings: The Accountable Health Communities Screening Tool NAM Perspectives. ,vol. 7, ,(2017) , 10.31478/201705B
Aaron K. Chatterji, Spawned with a silver spoon? Entrepreneurial performance and innovation in the medical device industry Strategic Management Journal. ,vol. 30, pp. 185- 206 ,(2009) , 10.1002/SMJ.729
D. R. Cox, Regression Models and Life-Tables Journal of the Royal Statistical Society: Series B (Methodological). ,vol. 34, pp. 187- 202 ,(1972) , 10.1111/J.2517-6161.1972.TB00899.X
David Dranove, David Meltzer, Do Important Drugs Reach the Market Sooner The RAND Journal of Economics. ,vol. 25, pp. 402- 423 ,(1994) , 10.2307/2555769